newsfilter
← Latest News
PR Newswire·

Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update

Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers...